Linked Life Data

8988665

Source:http://linkedlifedata.com/resource/pubmed/id/8988665

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1997-1-30
pubmed:abstractText
Regardless of surgical effectiveness, ongoing activity in parathyroid localization in hyperparathyroidism (HPT) is an established enterprise. Sestamibi (MIBI), the most recent new modality, is being assessed in this regard.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-9610
pubmed:author
pubmed:issnType
Print
pubmed:volume
172
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
633-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Evaluation of single isotope technetium 99M-sestamibi in localization efficiency for hyperparathyroidism.
pubmed:affiliation
Department of Radiology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article